Pradaxa is considered a high-alert medication because it can cause potentially fatal:

Respiratory depression is typically associated with opioid medications and certain anesthetics, not with anticoagulants like Pradaxa. While respiratory depression is a serious condition, it is not a common or recognized adverse effect of Pradaxa, making this choice incorrect in the context of high-alert medications.

Hyperglycemia refers to elevated blood sugar levels and is primarily associated with diabetes management and certain medications like corticosteroids. Pradaxa does not have a direct effect on blood glucose levels, and thus it is not linked to the serious risks that characterize high-alert medications.

Hypoxia is a condition characterized by insufficient oxygen in the tissues, often related to respiratory or circulatory issues. It is not a direct side effect of Pradaxa, which primarily affects coagulation pathways rather than oxygen delivery, thereby making this option irrelevant in the context of the medication's risks.